Branding/Logomark minus Citation Combined Shape Icon/Bookmark-empty Icon/Copy Icon/Collection Icon/Close Copy 7 no author result Created with Sketch. Icon/Back Created with Sketch. Match!
Ioanna Xanthopoulou
University of Patras
149Publications
20H-index
1,697Citations
Publications 149
Newest
Published on May 20, 2019in American Journal of Cardiovascular Drugs 2.58
Ovidio De Fillippo1
Estimated H-index: 1
(UNITO: University of Turin),
Martina Cortese1
Estimated H-index: 1
(UNITO: University of Turin)
+ 35 AuthorsLazar Velicki7
Estimated H-index: 7
(University of Novi Sad)
Published on Apr 27, 2019in American Journal of Cardiovascular Drugs 2.58
Ovidio De Filippo2
Estimated H-index: 2
(UNITO: University of Turin),
Ovidio De Fillippo1
Estimated H-index: 1
(UNITO: University of Turin)
+ 35 AuthorsChristian Templin27
Estimated H-index: 27
(UZH: University of Zurich)
Background Limited data are available concerning differences in clinical outcomes for real-life patients treated with ticagrelor versus prasugrel after percutaneous coronary intervention (PCI).
Published on May 1, 2019in Revista Espanola De Cardiologia 5.13
Sergio Raposeiras-Roubín13
Estimated H-index: 13
,
Emad Abu Assi16
Estimated H-index: 16
+ 46 AuthorsRafael Cobas-Paz1
Estimated H-index: 1
Abstract Introduction and objectives For patients with acute coronary syndrome (ACS) treated with percutaneous coronary intervention (PCI), it is unclear whether angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB) are associated with reduced mortality, particularly with preserved left ventricular ejection fraction (LVEF). The goal of this study was to determine the association between ACEI/ARB and mortality in ACS patients undergoing PCI, with and without reduc...
Sergio Raposeiras-Roubín13
Estimated H-index: 13
,
Emad Abu Assi16
Estimated H-index: 16
+ 46 AuthorsWouter J. Kikkert12
Estimated H-index: 12
(UvA: University of Amsterdam)
Background:The rate of intracranial haemorrhage after an acute coronary syndrome has been studied in detail in the era of thrombolysis; however, in the contemporary era of percutaneous coronary intervention, most of the data have been derived from clinical trials. With this background, we aim to analyse the incidence, timing, predictors and prognostic impact of post-discharge intracranial haemorrhage in patients with acute coronary syndrome undergoing percutaneous coronary intervention.Methods:W...
Published on Apr 1, 2019in Revista Espanola De Cardiologia 5.13
Sergio Raposeiras-Roubín13
Estimated H-index: 13
,
Emad Abu Assi16
Estimated H-index: 16
+ 35 AuthorsIoanna Xanthopoulou20
Estimated H-index: 20
Resumen Introduccion y objetivos Hay muy poca evidencia sobre las tasas de trombosis del stent (TS) en pacientes que reciben tratamiento antiagregante plaquetario doble (TAPD) con ticagrelor o prasugrel. El objetivo de este estudio es analizar la incidencia y predictores de la TS tras un sindrome coronario agudo en pacientes que reciben TAPD con ticagrelor frente a prasugrel. Metodos Se utilizaron datos del registro RENAMI (REgistry of New Antiplatelet therapy in patients with acute Myocardial I...
Published on Apr 1, 2019in Revista Espanola De Cardiologia 5.13
Sergio Raposeiras-Roubín13
Estimated H-index: 13
,
Emad Abu Assi16
Estimated H-index: 16
+ 35 AuthorsIoanna Xanthopoulou20
Estimated H-index: 20
Abstract Introduction and objectives There is little evidence on rates of stent thrombosis (ST) in patients receiving dual antiplatelet therapy (DAPT) with ticagrelor or prasugrel. The aim of this study was to analyze the incidence and predictors of ST after an acute coronary syndrome among patients receiving DAPT with ticagrelor vs prasugrel. Methods We used data from the RENAMI registry (REgistry of New Antiplatelet therapy in patients with acute Myocardial Infarction), analyzing a total of 41...
Published on Mar 12, 2019in European Journal of Preventive Cardiology 5.64
Fabrizio D’Ascenzo33
Estimated H-index: 33
(UNITO: University of Turin),
Maurizio Bertaina6
Estimated H-index: 6
(UNITO: University of Turin)
+ 38 AuthorsChristian Templin27
Estimated H-index: 27
(UZH: University of Zurich)
IntroductionThe benefits of short versus long-term dual antiplatelet therapy (DAPT) based on the third generation P2Y12 antagonists prasugrel or ticagrelor, in patients with acute coronary syndrome...
Published on Mar 1, 2019in Revista Espanola De Cardiologia 5.13
Sergio Raposeiras-Roubín13
Estimated H-index: 13
,
Berenice Caneiro Queija2
Estimated H-index: 2
+ 35 AuthorsEnrico Cerrato18
Estimated H-index: 18
Abstract Introduction and objectives The PARIS score allows combined stratification of ischemic and hemorrhagic risk in patients with ischemic heart disease treated with coronary stenting and dual antiplatelet therapy (DAPT). Its usefulness in patients with acute coronary syndrome (ACS) treated with ticagrelor or prasugrel is unknown. We investigated this issue in an international registry. Methods Retrospective multicenter study with voluntary participation of 11 centers in 6 European countries...
Published on Mar 1, 2019in Revista Espanola De Cardiologia 5.13
Sergio Raposeiras-Roubín13
Estimated H-index: 13
,
Berenice Caneiro Queija2
Estimated H-index: 2
+ 35 AuthorsEnrico Cerrato18
Estimated H-index: 18
Resumen Introduccion y objetivos La puntuacion PARIS permite una estratificacion combinada de los riesgos isquemico y hemorragico de los pacientes con cardiopatia isquemica tratados con stent coronario y tratamiento antiagregante plaquetario doble (TAPD). Se desconoce su utilidad en pacientes con sindrome coronario agudo (SCA) tratados con ticagrelor o prasugrel. Se investiga este aspecto en un registro internacional. Metodos Estudio retrospectivo multicentrico con participacion voluntaria de 11...
12345678910